Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered...

Related Keywords

China ,Shanghai ,Chinese ,Argo Biopharma ,Dongxu Shu ,Shaun Coughlin ,Novartis ,Prnewswire Shanghai Argo Biopharmaceutical Co Ltd ,Shanghai Argo Biopharmaceutical Co Ltd ,Greater China ,Metabolic Disease Area ,Hart Scott Rodino Antitrust Improvements ,Shanghai Argo Biopharmaceutical Co ,Td ,